Stay updated with breaking news from Arnaud bourdin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2021 NOV 25 By a News Reporter-Staff News Editor at Insurance Daily News A new study on sleep apnea is now available. According to news reporting originating from Nimes, France, by NewsRx correspondents, research stated,“ Primary Sjogren’ s syndrome is an autoimmune disease, associated with a high risk of lymphoma.”. Our news correspondents obtained a quote from the. ....
Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.
Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail ATS 2021, New York, NY - Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial. Tezepelumab offers new therapeutic opportunities for patients who are currently ineligible for biologic treatments, said study author/investigator Arnaud Bourdin, MD, professor, Département de Pneumologie et Addictologie, PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France. It may also challenge the current mandatory step of biomarker assessment before initiating a biologic. ....